Academic Office Phone: 504-988-2307
Clinic Phone: 504-988-5110
Clinic Fax: 504-988-3102
January 2020: Health and Fitness Magazine Cover Story
Dr. Kandil is a Professor of Surgery, the Elias Hanna Chair in Surgery and the Chief of General, Endocrine and Oncological Surgery Division at Tulane University Medical School, New Orleans, LA. He is also an executive member of the Tulane Cancer Executive Council and the director of the clinical Endocrine Surgery Fellowship at Tulane. He completed his training with a clinical fellowship in endocrine surgery at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Kandil is a fellow of the prestigious American Surgical Association and a member of the Southern Surgical Association. He is also a fellow of the American College of Surgeons and the American Association of Clinical Endocrinologists. He serves on several national and international committees and served on multiple institutional leadership positions including being the Chair of General Medical Faculty. Dr. Kandil has written approximately 300 original articles, invited reviews and book chapters and served on numerous editorial boards. Dr. Kandil has a special interest in robotic endocrine surgery and he has the largest experience in the country with robotic thyroid and parathyroid surgery. He has lectured all over the world on topics related to endocrine surgery. Dr. Kandil is the program director of an annual course on thyroid and parathyroid surgery – a program that is now in its 11th year.
His research interests have focused on clinical outcome research related to endocrine surgery. His laboratory research focus is on the identification of novel genetic markers and examining the anti-tumor efficacy of multiple pathways targeting thyroid cancer using in vitro and mouse-model cell in addition to human specimens. Learn more about Dr. Kandil's Research and Fellowships.
Endocrine tumor genetics and clinical outcome research for thyroid, parathyroid, and adrenal diseases. Dr. Kandil has a funded laboratory. Dr. Kandil’s research team focuses on translational research in thyroid cancer. We have a special interest in active surveillance, we aim to predict which patients may not need any surgical intervention, and which patients will do poorly. We then identify novel targeted therapies directed at the specific genetic mutations in thyroid...
Dr. Kandil makes sure that every patient gets state of the art care while receiving the best compassionate care, just like he would take care of his own family.